AU2003294217A1 - Human polypeptides encoded by polynucleotides and methods of their use - Google Patents

Human polypeptides encoded by polynucleotides and methods of their use

Info

Publication number
AU2003294217A1
AU2003294217A1 AU2003294217A AU2003294217A AU2003294217A1 AU 2003294217 A1 AU2003294217 A1 AU 2003294217A1 AU 2003294217 A AU2003294217 A AU 2003294217A AU 2003294217 A AU2003294217 A AU 2003294217A AU 2003294217 A1 AU2003294217 A1 AU 2003294217A1
Authority
AU
Australia
Prior art keywords
polynucleotides
methods
polypeptides encoded
human polypeptides
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294217A
Other versions
AU2003294217A8 (en
Inventor
Pierre Alvaro Beaurang
Dirk Behrens
Keting Chu
Lin Haishan
Robert Forgan Halenbeck
Kevin Hestir
Min Mei Huang
Srinivas Kothakota
Ernestine Lee
Thomas Linnemann
Kristen Pierce
Yan Wang
Lewis T. Williams
Justin G. P. Wong
Ge Wu
Hongbing Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Five Prime Therapeutics Inc
Original Assignee
Five Prime Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc filed Critical Five Prime Therapeutics Inc
Publication of AU2003294217A1 publication Critical patent/AU2003294217A1/en
Publication of AU2003294217A8 publication Critical patent/AU2003294217A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003294217A 2002-08-29 2003-08-28 Human polypeptides encoded by polynucleotides and methods of their use Abandoned AU2003294217A1 (en)

Applications Claiming Priority (136)

Application Number Priority Date Filing Date Title
US40664002P 2002-08-29 2002-08-29
US40664602P 2002-08-29 2002-08-29
US40658802P 2002-08-29 2002-08-29
US40661202P 2002-08-29 2002-08-29
US40657902P 2002-08-29 2002-08-29
US40661102P 2002-08-29 2002-08-29
US40660802P 2002-08-29 2002-08-29
US40661602P 2002-08-29 2002-08-29
US40665502P 2002-08-29 2002-08-29
US40658502P 2002-08-29 2002-08-29
US40657602P 2002-08-29 2002-08-29
US40665302P 2002-08-29 2002-08-29
US40664202P 2002-08-29 2002-08-29
US40666602P 2002-08-29 2002-08-29
US60/406,653 2002-08-29
US60/406,655 2002-08-29
US60/406,666 2002-08-29
US60/406,576 2002-08-29
US60/406,611 2002-08-29
US60/406,646 2002-08-29
US60/406,585 2002-08-29
US60/406,608 2002-08-29
US60/406,640 2002-08-29
US60/406,579 2002-08-29
US60/406,612 2002-08-29
US60/406,642 2002-08-29
US60/406,588 2002-08-29
US60/406,616 2002-08-29
US60/411,032 2002-09-16
US41103502P 2002-09-17 2002-09-17
US41104802P 2002-09-17 2002-09-17
US41110102P 2002-09-17 2002-09-17
US41102302P 2002-09-17 2002-09-17
US41095802P 2002-09-17 2002-09-17
US41102202P 2002-09-17 2002-09-17
US41104502P 2002-09-17 2002-09-17
US41101902P 2002-09-17 2002-09-17
US41094902P 2002-09-17 2002-09-17
US41105202P 2002-09-17 2002-09-17
US41096002P 2002-09-17 2002-09-17
US41105502P 2002-09-17 2002-09-17
US41096202P 2002-09-17 2002-09-17
US41104102P 2002-09-17 2002-09-17
US41096102P 2002-09-17 2002-09-17
US41094602P 2002-09-17 2002-09-17
US41111102P 2002-09-17 2002-09-17
US41094802P 2002-09-17 2002-09-17
US41104602P 2002-09-17 2002-09-17
US41095302P 2002-09-17 2002-09-17
US41107302P 2002-09-17 2002-09-17
US41094702P 2002-09-17 2002-09-17
US41102402P 2002-09-17 2002-09-17
US41095902P 2002-09-17 2002-09-17
US41103702P 2002-09-17 2002-09-17
US41108202P 2002-09-17 2002-09-17
US41095702P 2002-09-17 2002-09-17
US60/411,101 2002-09-17
US60/410,949 2002-09-17
US60/411,037 2002-09-17
US60/410,953 2002-09-17
US60/411,073 2002-09-17
US60/410,958 2002-09-17
US60/411,052 2002-09-17
US60/411,024 2002-09-17
US60/411,023 2002-09-17
US60/411,041 2002-09-17
US60/411,019 2002-09-17
US60/411,082 2002-09-17
US60/410,957 2002-09-17
US60/410,946 2002-09-17
US60/411,111 2002-09-17
US60/410,960 2002-09-17
US60/410,962 2002-09-17
US60/411,035 2002-09-17
US60/410,961 2002-09-17
US60/410,948 2002-09-17
US60/411,055 2002-09-17
US60/410,959 2002-09-17
US60/411,048 2002-09-17
US60/411,022 2002-09-17
US60/411,045 2002-09-17
US60/410,947 2002-09-17
US60/411,046 2002-09-17
US46370803P 2003-04-18 2003-04-18
US46370003P 2003-04-18 2003-04-18
US46371603P 2003-04-18 2003-04-18
US46373203P 2003-04-18 2003-04-18
US60/463,708 2003-04-18
US60/463,716 2003-04-18
US60/463,732 2003-04-18
US60/463,700 2003-04-18
US46720103P 2003-05-02 2003-05-02
US46723003P 2003-05-02 2003-05-02
US46719903P 2003-05-02 2003-05-02
US46720303P 2003-05-02 2003-05-02
US60/467,203 2003-05-02
US60/467,199 2003-05-02
US60/467,201 2003-05-02
US60/467,230 2003-05-02
US47130603P 2003-05-19 2003-05-19
US47133603P 2003-05-19 2003-05-19
US60/471,336 2003-05-19
US60/471,306 2003-05-19
US47243003P 2003-05-22 2003-05-22
US47242003P 2003-05-22 2003-05-22
US60/472,420 2003-05-22
US60/472,430 2003-05-22
US47660903P 2003-06-09 2003-06-09
US47664103P 2003-06-09 2003-06-09
US60/476,641 2003-06-09
US60/476,609 2003-06-09
US48522403P 2003-07-08 2003-07-08
US48532503P 2003-07-08 2003-07-08
US48521803P 2003-07-08 2003-07-08
US48522303P 2003-07-08 2003-07-08
US60/485,325 2003-07-08
US60/485,218 2003-07-08
US60/485,223 2003-07-08
US60/485,224 2003-07-08
US48644603P 2003-07-14 2003-07-14
US48648003P 2003-07-14 2003-07-14
US60/486,446 2003-07-14
US60/486,480 2003-07-14
US48696003P 2003-07-15 2003-07-15
US48689103P 2003-07-15 2003-07-15
US60/486,891 2003-07-15
US60/486,960 2003-07-15
US49357703P 2003-08-08 2003-08-08
US49334103P 2003-08-08 2003-08-08
US49357303P 2003-08-08 2003-08-08
US49337003P 2003-08-08 2003-08-08
US60/493,341 2003-08-08
US60/493,370 2003-08-08
US60/493,577 2003-08-08
US60/493,573 2003-08-08
PCT/US2003/026780 WO2004035732A2 (en) 2002-08-29 2003-08-28 Human polypeptides encoded by polynucleotides and methods of their use

Publications (2)

Publication Number Publication Date
AU2003294217A1 true AU2003294217A1 (en) 2004-05-04
AU2003294217A8 AU2003294217A8 (en) 2004-05-04

Family

ID=37714949

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294217A Abandoned AU2003294217A1 (en) 2002-08-29 2003-08-28 Human polypeptides encoded by polynucleotides and methods of their use

Country Status (2)

Country Link
AU (1) AU2003294217A1 (en)
WO (1) WO2004035732A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005229434B2 (en) * 2004-03-30 2010-09-30 Nsgene A/S Therapeutic use of a growth factor, NsG33

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0401730D0 (en) * 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
WO2005101004A2 (en) * 2004-04-13 2005-10-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1)
BRPI0513329A (en) * 2004-07-12 2008-05-13 Cropdesign Nv method for improving plant growth characteristics, plants, construction, method for producing a transgenic plant, transgenic plant, collectible parts of a plant, products, and use of a yippee-like gene or nucleic acid or variant thereof or use of a yippee-like or homologous polypeptide thereof
EP1627922A1 (en) 2004-08-18 2006-02-22 Sanofi-Aventis Deutschland GmbH Method of screening for a carnitine transporter agonist or antagonist and its uses
EP1885755A4 (en) 2005-05-05 2009-07-29 Univ Duke Anti-cd19 antibody therapy for autoimmune disease
US7354904B2 (en) * 2005-12-08 2008-04-08 The United States Of America As Represented By The Secretary Of Agriculture Bacteriocin inducer peptides
CA2656192C (en) 2006-06-30 2016-05-03 Ambit Biosciences Corporation Detectable nucleic acid tag
US8298545B2 (en) * 2007-02-07 2012-10-30 The Trustees Of The University Of Pennsylvania Anti-autoimmune antibodies for treatment of pemphigus
AU2008290060B2 (en) * 2007-08-20 2014-04-24 Oncotherapy Science, Inc. CDH3 peptide and medicinal agent comprising the same
GB0803352D0 (en) * 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
CA2730710C (en) 2008-07-24 2021-06-08 Nsgene A/S Therapeutic use of a growth factor, metrnl
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
JP2012524907A (en) 2009-04-24 2012-10-18 ディスカヴァーエックス コーポレイション Cell analysis using detectable proteins
US20110117168A1 (en) 2009-11-18 2011-05-19 Affinergy, Inc. Methods and compositions for soft tissue repair
CN103269708A (en) 2010-10-01 2013-08-28 Ns基因公司 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
US9474786B2 (en) 2011-09-05 2016-10-25 Nsgene A/S Treatment of allodynia
WO2014071200A1 (en) * 2012-11-02 2014-05-08 The Regents Of The University Of Colorado, A Body Corporate Beta blocker responder status assays and related materials and methods
US9944700B2 (en) 2013-03-13 2018-04-17 Novartis Ag Notch2 binding molecules for treating respiratory diseases
EP3604332A1 (en) * 2013-12-20 2020-02-05 Novartis AG Novel eukaryotic cells and methods for recombinantly expressing a product of interest
CA2934411C (en) 2013-12-20 2022-05-03 Novartis Ag Novel eukaryotic cells and methods for recombinantly expressing a product of interest
EP2899205A1 (en) 2014-01-23 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Interaction of Draxin and y-Netrins
WO2016073845A1 (en) * 2014-11-07 2016-05-12 Igenica Biotherapeutics, Inc. Anti-cd39 antibodies and uses thereof
WO2022136440A1 (en) * 2020-12-21 2022-06-30 Syngenta Crop Protection Ag Pesticidal hexatoxin polypeptides and methods of use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005229434B2 (en) * 2004-03-30 2010-09-30 Nsgene A/S Therapeutic use of a growth factor, NsG33

Also Published As

Publication number Publication date
WO2004035732A3 (en) 2006-01-26
WO2004035732A2 (en) 2004-04-29
AU2003294217A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
AU2003294217A1 (en) Human polypeptides encoded by polynucleotides and methods of their use
EP1576169A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001265009A1 (en) Human polynucleotides and polypeptides encoded thereby
AU2003295343A1 (en) Uses of human zven proteins and polynucleotides
AU2001280608A1 (en) Human polynucleotides and polypeptides encoded thereby
AU2003217956A1 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
AU2003298606A1 (en) Human polypeptides encoded by polynucleotides and methods of their use
AU2002334781A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003265787A1 (en) Methods of use for novel human polypeptides encoded by polynucleotides
EP1549671A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003023002A9 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003294236A1 (en) Methods of use for novel human polypeptides encoded by polynucleotides
AU2003284967A1 (en) Novel mouse polypeptides encoded by polynucleotides and methods of their use
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2003060149A9 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003304034A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002318186A1 (en) Novel human kielin-like proteins and polynucleotides encoding the same
AU2003270424A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002345407A1 (en) Human cervical cancer 5 protooncogene and protein encoded therein
EP1587829A4 (en) Human protooncogene and protein encoded therein
AU2002322404A8 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP1513864A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1539807A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1551440A4 (en) Uses of human zven proteins and polynucleotides
AU2002359252A1 (en) Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase